secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0001104659-25-065842
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma appoints Charles Parker as Interim CFO, effective July 5, 2025, replacing Nora Brennan
--------------------------------------------------------------------------------

- Nora Brennan resigns as Interim CFO effective July 5, 2025; no severance, will provide transition services as independent contractor through July 18.
- Board appoints Charles Parker as Interim CFO effective July 5; he is a Director at Stout, a global advisory firm.
- Parker has over two decades of biopharma finance experience, including $700M+ capital raises and multi-million dollar debt restructurings.
- Compensation terms for Parker not yet finalized; disclosure expected when consulting agreement is completed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925065842/0001104659-25-065842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925065842/tm2519404d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-065842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer